Simplicity Wealth’s Terns Pharmaceuticals TERN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-10,561
Closed -$71.9K 1125
2024
Q2
$71.9K Buy
+10,561
New +$64K ﹤0.01% 1189

Other funds holding TERN

Simplicity Wealth's TERN Position: Q3 2024 in Review

Simplicity Wealth sold out of Terns Pharmaceuticals (TERN) in Q3 2024, closing a stake of 10,561 shares — an estimated $71.9K sold.

Simplicity Wealth first reported a position in TERN in Q2 2024 and held it in 1 quarter. The position peaked at $71.9K in Q2 2024. 156 funds tracked by Wall St. Rank hold TERN as of Q3 2024.

  • Simplicity Wealth reported no remaining Terns Pharmaceuticals position as of Q3 2024 after selling out during the quarter.
  • Simplicity Wealth sold 10,561 Terns Pharmaceuticals shares in Q3 2024, an estimated $71.9K.
  • Simplicity Wealth first reported a position in Terns Pharmaceuticals in Q2 2024 and held it in 1 quarter.
  • Simplicity Wealth's Terns Pharmaceuticals position peaked at $71.9K in Q2 2024.
  • 156 funds tracked by Wall St. Rank held Terns Pharmaceuticals as of Q3 2024.

Based on Simplicity Wealth's 13F filing for Q3 2024, filed 10 Oct 2024.